Metabolize

About

Metabolize is pioneering a new category of human nutrition called precision metabolites. Precision metabolites deliver specific biological signals our bodies already use to regulate appetite and metabolism. No drugs. No injections. No brute force stimulation. This is not supplementation as usual. This is metabolic signaling, made precise.

Product

Value proposition

A precision metabolite designed to deliver body’s natural fullness signals to support satiety, especially after GLP-1 medications, enabling sustained weight management

Target customers

US healthcare consumers seeking weight management solutions and patients on GLP-1 therapies

Founders

• Morris Laster — Co-Founder & CEO
• Gideon Meir — Co-Founder & COO

Products

Key features

Technologies

Target conditions

Investors

News

• Q&A: Metabolize, A Solution to GLP-1 Rebound - SOSV · 2026-01-26T14:22:39.000Z
• Metabolize - LinkedIn · 2026-01-30T00:00:00.000Z
• Harnessing Our Own Bodies For Side Effect-Free Weight Loss · 2024-09-30T12:33:42.000Z
• Metabolize Licenses Two Proprietary Metabolites to Address Obesity from Stanford OTL · 2024-07-30T17:16:00.000Z
• Metabolize Unveils Groundbreaking Weight Reduction Metabolite, with Breakthrough Findings Published in Nature · 2024-09-10T13:00:00.000Z
• Israel Startup Licenses Stanford Institute Metabolites To Develop ... · 2024-09-01T00:00:00.000Z

Browse similar startups

Related startups

• Metanoia Bio Inc. — los angeles, CA
• Metriq Health — Thousand Oaks, CA
• Miga — San Francisco, CA
• Mind-Sync — San Francisco, CA
• Mitos Diagnostics — San Francisco, CA
• Moona Health — San Francisco, CA
• Metfora Diagnostics — Tucson, AZ
• Meto — New York City, NY
• MettaH — Asheville, NC
• Milieu — Ann Arbor, MI
• MILLTOWN VISION CARE — Milltown, NJ
• Mina Modaresi DDS — Sterling, VA